Piper Sandler Lowers Colgate-Palmolive (NYSE:CL) Price Target to $112.00

Colgate-Palmolive (NYSE:CL - Get Free Report) had its target price dropped by analysts at Piper Sandler from $121.00 to $112.00 in a report released on Monday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Piper Sandler's price objective suggests a potential upside of 28.12% from the company's previous close.

Several other brokerages have also recently weighed in on CL. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research note on Monday, October 28th. StockNews.com upgraded Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Wednesday, January 1st. TD Cowen lowered their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, October 28th. Stifel Nicolaus downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating and boosted their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $104.63.

Colgate-Palmolive Stock Performance

NYSE:CL traded down $2.73 during mid-day trading on Monday, hitting $87.42. 6,076,701 shares of the stock were exchanged, compared to its average volume of 4,128,070. The firm's 50-day simple moving average is $93.35 and its 200 day simple moving average is $98.44. The stock has a market capitalization of $71.42 billion, a price-to-earnings ratio of 25.05, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company's stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.34% of the company's stock.

Institutional Trading of Colgate-Palmolive

A number of institutional investors have recently bought and sold shares of the company. Advisor OS LLC grew its stake in Colgate-Palmolive by 4.5% during the second quarter. Advisor OS LLC now owns 2,348 shares of the company's stock worth $228,000 after purchasing an additional 101 shares during the period. D Orazio & Associates Inc. grew its position in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company's stock worth $297,000 after buying an additional 108 shares during the period. Fiducient Advisors LLC increased its stake in shares of Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company's stock valued at $232,000 after acquiring an additional 110 shares in the last quarter. Wealthspire Advisors LLC lifted its position in shares of Colgate-Palmolive by 3.0% during the 2nd quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company's stock valued at $374,000 after acquiring an additional 111 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its stake in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company's stock worth $2,117,000 after acquiring an additional 113 shares in the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.